Protection still high six months after second dose
Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, six months after second doses, study finds. Protection against severe COVID-19 by two doses of...
The COVID-19 category provides evidence-informed insight into the ongoing pandemic and its impacts on health, society and healthcare systems. It covers research updates, long-term effects, vaccines and policy discussions, helping readers understand developments and implications as the landscape continues to evolve.